Marfan syndrome is definitely a hereditary disorder principally affecting the connective cells of the body, often seen as a excessive bone elongation and joint flexibility and abnormalities of the optical eye and heart. Progressive aortic rupture and dilation will be the most significant complications and the most common cause of premature death. Beta-blockers are currently the standard treatment for MFS, but may not be as effective as various other therapies in treating aortic wall degeneration, according to history information in the article. Angiotensin-transforming enzyme inhibitors have been shown to decrease arterial stiffness.Related StoriesNew medical trial on breast malignancy may help deal with and control diseaseBerkeley Laboratory scientists identify genetic elements that influence neurological disorders and body weightResearchers find better genetic diversity among cancer cells than anticipatedStill, she cautioned that these findings need to be verified with longer follow-up. The data for better results from higher-intensity therapy goes back to 2000, when Stock and UChicago pediatric oncologist James Nachman examined ALL trials conducted over the last a decade by two malignancy cooperative organizations, one pediatric and one adult. They found a sensational difference. ALL patients age range 16 to 21 who enrolled in pediatric trials experienced a progression-free survival rate of 68 %.